{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:00:17Z","timestamp":1788829217909,"version":"build-2803163510"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>This review provides a detailed overview of how digital health can be utilized in the management of Interstitial Lung Disease (ILD), and Chronic Obstructive Pulmonary Disease (COPD). ILD encompasses a diverse range of lung disorders characterized by inflammation and scarring of lung tissue, leading to restrictive lung physiology and impaired gas exchange, with symptoms including progressive dyspnoea, cough, and hypoxia. COPD which ranks as the third leading cause of death globally, is characterized by chronic lung inflammation causing irreversible airflow obstruction, recurrent exacerbations. While recent advances in digital health have shown promise, predicting disease progression in patients with ILD and exacerbation in patients with COPD remains challenging. This review explores the role of digital health in managing ILD and COPD, particularly focusing on telehealth and digital health technologies. Telehealth, defined broadly as the use of electronic information and telecommunications technologies in healthcare, has become increasingly relevant, especially during the COVID-19 pandemic. This review examines the role of digital health technologies in the management of ILD and COPD, with particular focus on telemedicine, and digital health tools. Remote monitoring technologies, including home spirometry and wearable devices, have demonstrated feasibility in managing respiratory diseases. However, challenges such as evidence, data reliability, varying adherence, education, and the high costs of data collection and lack of qualified clinicians present barriers for many national health systems.<\/jats:p>","DOI":"10.3389\/fmed.2025.1361667","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:15:25Z","timestamp":1740546925000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["The role of digital health in respiratory diseases management: a narrative review of recent literature"],"prefix":"10.3389","volume":"12","author":[{"given":"Malik A.","family":"Althobiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatharth","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos A.","family":"Folarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna C.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"ref1","volume-title":"Global strategy on digital health 2020\u20132025","year":"2020"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jval.2021.09.008","article-title":"A cost-utility analysis of remote pulse-oximetry monitoring of patients with COVID-19","volume":"25","author":"Padula","year":"2022","journal-title":"Value Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/PTS.0000000000000696","article-title":"Inpatient respiratory arrest associated with sedative and analgesic medications: impact of continuous monitoring on patient mortality and severe morbidity","volume":"17","author":"McGrath","year":"2021","journal-title":"J Patient Saf"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/jamia\/ocaa168","article-title":"Home telemonitoring makes early hospital discharge of COVID-19 patients possible","volume":"27","author":"Grutters","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/jama.2022.2040","article-title":"Remote patient monitoring during COVID-19: An unexpected patient safety benefit","volume":"327","author":"Pronovost","year":"2022","journal-title":"JAMA"},{"key":"ref6","volume-title":"Global strategy for prevention, diagnosis and management of COPD: 2024 report","year":"2024"},{"key":"ref7","volume-title":"Chronic obstructive pulmonary disease (COPD) statistics","year":"2022"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"8","author":"Soriano","year":"2020","journal-title":"Lancet Respir Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(22)01273-9","article-title":"Towards the elimination of chronic obstructive pulmonary disease: a lancet commission","volume":"400","author":"Stolz","year":"2022","journal-title":"Lancet"},{"key":"ref10","volume-title":"Chronic obstructive pulmonary disease (COPD)","year":"2023"},{"key":"ref11","volume-title":"The battle for breath: The impact of lung disease in the UK: British Lung Foundation","year":"2016"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fmed.2024.1296890","article-title":"Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment","volume":"11","author":"Althobiani","year":"2024","journal-title":"Front Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12931-022-02297-y","article-title":"Recognising the importance of chronic lung disease: a consensus statement from the global Alliance for chronic diseases (lung diseases group)","volume":"24","author":"Gould","year":"2023","journal-title":"Respir Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1164\/rccm.201501-0044ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease","volume":"191","author":"Celli","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12931-015-0167-9","article-title":"Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study","volume":"16","author":"Brill","year":"2015","journal-title":"Respir Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41533-019-0117-y","article-title":"COPD\u2019s early origins in low-and-middle income countries: what are the implications of a false start?","volume":"29","author":"Brakema","year":"2019","journal-title":"NPJ Prim Care Respir Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2213-2600(21)00227-7","article-title":"Research priorities for exacerbations of COPD","volume":"9","author":"Alqahtani","year":"2021","journal-title":"Lancet Respir Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"00441","DOI":"10.1183\/23120541.00441-2021","article-title":"Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review","volume":"7","author":"Althobiani","year":"2021","journal-title":"ERJ Open Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S2213-2600(22)00228-4","article-title":"Home monitoring in interstitial lung diseases","volume":"11","author":"Wijsenbeek","year":"2023","journal-title":"Lancet Respir Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2466-10-52","article-title":"Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study","volume":"10","author":"Hurst","year":"2010","journal-title":"BMC Pulm Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carf\u00ec","year":"2020","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/thoraxjnl-2020-215818","article-title":"'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19","volume":"76","author":"Mandal","year":"2021","journal-title":"Thorax"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S2213-2600(21)00383-0","article-title":"Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study","volume":"9","author":"Evans","year":"2021","journal-title":"Lancet Respir Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e19992","DOI":"10.2196\/19992","article-title":"Using smartphones and wearable devices to monitor behavioral changes during COVID-19","volume":"22","author":"Sun","year":"2020","journal-title":"J Med Internet Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"100619","DOI":"10.1016\/j.lanepe.2023.100619","article-title":"Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study","volume":"29","author":"Halpin","year":"2023","journal-title":"Lancet Reg Health"},{"key":"ref26","article-title":"What is telehealth?","year":"2022"},{"key":"ref27","volume-title":"What is telehealth?","year":"2018"},{"key":"ref28","first-page":"97","article-title":"That \u2018internet of things\u2019 thing","volume":"22","author":"Ashton","year":"2009","journal-title":"RFID J"},{"key":"ref29","article-title":"Internet of things in E-business","author":"Charmonman","year":"2015"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/13645706.2019.1575882","article-title":"Introduction to artificial intelligence in medicine","volume":"28","author":"Mintz","year":"2019","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.scs.2018.01.053","article-title":"Towards sustainable smart cities: A review of trends, architectures, components, and open challenges in smart cities","volume":"38","author":"Silva","year":"2018","journal-title":"Sustain Cities Soc"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jii.2018.01.005","article-title":"5G internet of things: A survey","volume":"10","author":"Li","year":"2018","journal-title":"J Ind Inf Integr"},{"key":"ref33","first-page":"488","article-title":"Industrial internet: pushing the boundaries","volume-title":"General Electric Reports","author":"Evans","year":"2012"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"183339","DOI":"10.1109\/ACCESS.2019.2960617","article-title":"Security and privacy for the internet of medical things enabled healthcare systems: A survey","volume":"7","author":"Sun","year":"2019","journal-title":"IEEE Access"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s12083-019-00823-2","article-title":"IOT based wearable sensor for diseases prediction and symptom analysis in healthcare sector","volume":"13","author":"Muthu","year":"2020","journal-title":"Peer Peer Netw Appl"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ceh.2023.12.002","article-title":"Post pandemic analysis on comprehensive utilization of telehealth and telemedicine","volume":"7","author":"Ndwabe","year":"2024","journal-title":"Clin eHealth"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e001837","DOI":"10.1136\/bmjresp-2023-001837","article-title":"Patient perspectives on home-spirometry in interstitial lung disease: a qualitative co-designed study","volume":"10","author":"Mandizha","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-022-02221-4","article-title":"A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease","volume":"23","author":"Maher","year":"2022","journal-title":"Respir Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e0000318","DOI":"10.1371\/journal.pdig.0000318","article-title":"Supporting self-management for patients with interstitial lung diseases: utility and acceptability of digital devices","volume":"3","author":"Althobiani","year":"2024","journal-title":"PLOS Digit Health"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/thoraxjnl-2019-213620","article-title":"Risk factors for disease progression in idiopathic pulmonary fibrosis","volume":"75","author":"Raghu","year":"2020","journal-title":"Thorax"},{"key":"ref41","first-page":"e0000318","article-title":"A randomized controlled trial of a home monitoring program in newly treated patients with idiopathic pulmonary fibrosis","volume":"201","author":"Moor","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/jpm9020023","article-title":"Feasibility of a comprehensive home monitoring program for sarcoidosis","volume":"9","author":"Moor","year":"2019","journal-title":"J Pers Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12931-018-0810-3","article-title":"A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers","volume":"19","author":"Moor","year":"2018","journal-title":"Respir Res"},{"key":"ref44","volume-title":"mHealth: New horizons for health through mobile technologies","year":"2011"},{"key":"ref45","volume-title":"Technology enabled care services: Resource for commissioners","year":"2015"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1164\/rccm.202210-1949LE","article-title":"Clinicians\u2019 and researchers\u2019 perspectives on a new chronic obstructive pulmonary disease exacerbation definition: Rome Wasn\u2019t built in a day","volume":"207","author":"Althobiani","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e17597","DOI":"10.2196\/17597","article-title":"Once daily versus overnight and symptom versus physiological monitoring to detect exacerbations of chronic obstructive pulmonary disease: pilot randomized controlled trial","volume":"8","author":"al","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41746-023-00962-0","article-title":"Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"6","author":"Shah","year":"2023","journal-title":"NPJ Digital Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fmed.2021.720019","article-title":"Effectiveness of Telemonitoring for reducing exacerbation occurrence in COPD patients with past exacerbation history: A systematic review and Meta-analysis","volume":"8","author":"Lu","year":"2021","journal-title":"Front Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e33185","DOI":"10.2196\/33185","article-title":"Telemedical interventions for chronic obstructive pulmonary disease management: umbrella review","volume":"25","author":"Koh","year":"2023","journal-title":"J Med Internet Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41746-023-00908-6","article-title":"Implications for implementation and adoption of telehealth in developing countries: a systematic review of China\u2019s practices and experiences","volume":"6","author":"Ye","year":"2023","journal-title":"NPJ Digital Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e021865","DOI":"10.1136\/bmjopen-2018-021865","article-title":"Telehealth for patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis protocol","volume":"8","author":"Gaveikaite","year":"2018","journal-title":"BMJ Open"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"CD013196","DOI":"10.1002\/14651858.CD013196.pub2","article-title":"Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD)","volume":"7","author":"Janjua","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e51507","DOI":"10.2196\/51507","article-title":"Evaluating a remote monitoring program for respiratory diseases: prospective observational study","volume":"7","author":"Althobiani","year":"2023","journal-title":"JMIR Form Res"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1093\/rheumatology\/keaa607","article-title":"Feasibility of online home spirometry in systemic sclerosis\u2013associated interstitial lung disease: a pilot study","volume":"60","author":"Moor","year":"2021","journal-title":"Rheumatology"},{"key":"ref57","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A2575","article-title":"Home spirometry as a primary endpoint in clinical trials: sensitivity analyses of a randomized controlled trial of Pirfenidone in patients with unclassifiable interstitial lung disease (UILD)","author":"Maher","year":"2020"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1164\/rccm.201511-2152OC","article-title":"Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis","volume":"194","author":"Russell","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"00054","DOI":"10.1183\/23120541.00054-2020","article-title":"Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry","volume":"6","author":"Moor","year":"2020","journal-title":"ERJ Open Res"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1702089","DOI":"10.1183\/13993003.02089-2017","article-title":"Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis","volume":"51","author":"Broos","year":"2018","journal-title":"Eur Respir J"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000079642","article-title":"Value of spirometry in detecting volume restriction in interstitial lung disease patients: spirometry in interstitial lung diseases","volume":"71","author":"Boros","year":"2004","journal-title":"Respiration"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2001518","DOI":"10.1183\/13993003.01518-2020","article-title":"Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial","volume":"58","author":"Noth","year":"2021","journal-title":"Eur Respir J"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/resp.14708","article-title":"Home monitoring to detect progression of interstitial lung disease: A prospective cohort study","volume":"29","author":"Althobiani","year":"2024","journal-title":"Respirology"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1602406","DOI":"10.1183\/13993003.02406-2016","article-title":"Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis","volume":"50","author":"Johannson","year":"2017","journal-title":"Eur Respir J"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1702508","DOI":"10.1183\/13993003.02508-2017","article-title":"Development and feasibility of an eHealth tool for idiopathic pulmonary fibrosis","volume":"51","author":"Moor","year":"2018","journal-title":"Eur Respir J"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1164\/rccm.202002-0328OC","article-title":"Home monitoring in patients with idiopathic pulmonary fibrosis. A randomized controlled trial","volume":"202","author":"Moor","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1513\/AnnalsATS.201904-335RL","article-title":"Mobile health monitoring in patients with idiopathic pulmonary fibrosis","volume":"16","author":"Marcoux","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e16158","DOI":"10.2196\/16158","article-title":"Use of the patientMpower app with home-based spirometry to monitor the symptoms and impact of fibrotic lung conditions: longitudinal observational study","volume":"8","author":"Edwards","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12931-020-01524-8","article-title":"Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study","volume":"21","author":"Veit","year":"2020","journal-title":"Respir Res"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1513\/AnnalsATS.202105-612RL","article-title":"Clinical utility of home versus hospital spirometry in fibrotic interstitial lung disease: evaluation after INJUSTIS interim analysis","volume":"19","author":"Khan","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/jpm13050793","article-title":"Home-based spirometry in patients with interstitial lung diseases: A real-life pilot \u201cFACT\u201d study from Serbia","volume":"13","author":"Ili\u0107","year":"2023","journal-title":"J Pers Med"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12931-022-02061-2","article-title":"Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study","volume":"23","author":"Miedema","year":"2022","journal-title":"Respir Res"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1524-4733.2008.00470.x","article-title":"Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report","volume":"12","author":"Coons","year":"2009","journal-title":"Value Health"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1513\/AnnalsATS.202010-1318ST","article-title":"Electronic health records and pulmonary function data: developing an interoperability roadmap. An official American Thoracic Society workshop report","volume":"18","author":"McCormack","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"e15588","DOI":"10.2196\/15588","article-title":"Benefits and disadvantages of electronic patient-reported outcome measures: systematic review","volume":"3","author":"Meirte","year":"2020","journal-title":"JMIR Perioper Med"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.2196\/jmir.3.2.e20","article-title":"What is e-health?","volume":"3","author":"Eysenbach","year":"2001","journal-title":"J Med Internet Res"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"00124","DOI":"10.1183\/23120541.00124-2019","article-title":"Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey","volume":"5","author":"Moor","year":"2019","journal-title":"ERJ Open Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"170051","DOI":"10.1183\/16000617.0051-2017","article-title":"Evaluating disease severity in idiopathic pulmonary fibrosis","volume":"26","author":"Robbie","year":"2017","journal-title":"Eur Respir Rev"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1164\/rccm.202105-1193ST","article-title":"Patient-centered outcomes research in interstitial lung disease: An official American Thoracic Society research statement","volume":"204","author":"Aronson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/thoraxjnl-2012-202640","article-title":"Forced vital capacity as a primary end point in idiopathic pulmonary fibrosis treatment trials: making a silk purse from a sow's ear","volume":"68","author":"Wells","year":"2013","journal-title":"Thorax"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir Med"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1016\/S2589-7500(22)00111-X","article-title":"Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses","volume":"4","author":"Ferguson","year":"2022","journal-title":"Lancet Digital Health"},{"key":"ref84","volume-title":"Physical activity fact sheet","year":"2021"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-017-0495-2","article-title":"Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen","volume":"17","author":"Root","year":"2017","journal-title":"BMC Pulm Med"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12890-017-0444-0","article-title":"Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis","volume":"17","author":"Bahmer","year":"2017","journal-title":"BMC Pulm Med"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e001088","DOI":"10.1136\/bmjresp-2021-001088","article-title":"Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians","volume":"8","author":"Althobiani","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2147\/COPD.S405386","article-title":"Clinicians\u2019 perspectives of wearable technology to detect and monitor exacerbations of chronic obstructive pulmonary disease: mixed-method survey","volume":"18","author":"Althobiani","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e35474","DOI":"10.1016\/j.heliyon.2024.e35474","article-title":"The acceptability of wearable technology for long-term respiratory disease: A cross-sectional survey","volume":"10","author":"Shah","year":"2024","journal-title":"Heliyon"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"e11734","DOI":"10.2196\/11734","article-title":"RADAR-base: open source mobile health platform for collecting, monitoring, and analyzing data using sensors, wearables, and Mobile devices","volume":"7","author":"Ranjan","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jobcr.2021.11.010","article-title":"Potential of internet of medical things (IoMT) applications in building a smart healthcare system: A systematic review","volume":"12","author":"Dwivedi","year":"2022","journal-title":"J Oral Biol Craniofacial Res"},{"key":"ref92","first-page":"PA2241","article-title":"Adherence to home spirometry among patients with IPF: results from the INMARK trial","volume":"54","author":"Noth","year":"2019","journal-title":"Eur Respir J"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1361667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:15:32Z","timestamp":1740546932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1361667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":92,"alternative-id":["10.3389\/fmed.2025.1361667"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1361667","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"article-number":"1361667"}}